ong-term peginterferon monotherapy following 72 weeks of peginterferon and ribavirin in hepatitis C genotype-1 infected slow responders
Not Applicable
- Conditions
- Hepatitis C
- Registration Number
- JPRN-UMIN000013069
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Case that was complicated with a malignant tumor Cirrhosis case of the decompensation period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response
- Secondary Outcome Measures
Name Time Method